학술논문
Role of immunohistochemistry and flow cytometry in minimal residual disease detection in NPM1‐mutated AML.
Document Type
Letter to the Editor
Source
Subject
*FLOW cytometry
*GENETIC mutation
*IMMUNOHISTOCHEMISTRY
*CARCINOGENESIS
*ACUTE myeloid leukemia
*RISK assessment
*GENES
*POLYMERASE chain reaction
*
*
*
*
*
*
*
Language
ISSN
1751-5521